The identification of genetic alterations is key to be able to administer targeted therapies to each patient.

This is a collaborative work of the Spanish Society of Pediatric Hematology and Oncology that aims to promote precision medicine in the national health system.

Som centre estatal de referència per al trasplantament de progenitors hematopoètics o cèl·lules mare, amb 1.417 trasplantaments realitzats: fa una dècada que vam obtenir l’acreditació JACIE, la més prestigiosa de l’àmbit europeu.

The Vall d’Hebron Barcelona Hospital Campus has organised the World Cancer Day Conference as part of World Cancer Day, today, 4 February.

It is first proof of concept for the delivery of a tumor-suppressive microRNA for the treatment of neuroblastoma, a highly-aggressive pediatric solid tumor of the peripheral nervous system.

The donation will boost the research headed by Dr Josep Roma, researcher with the VHIR Childhood Cancer and Haematological Diseases group.

Dr. Lucas Moreno and Dr. Constantino Sábado, researchers of the Translational Research Group in Childhood and Adolescent Cancer, are two of the leaders of the international study.

The study shows the therapeutic effect of a new drug called 4SC-205 in new mouse neuroblastoma models, where it is effective in reducing the growth of the tumour.

The solidarity activities of the foundation allow them to raise more money every year for the research of this disease.

The Fight Kids Cancer initiative (a union of three European cancer associations: Imagine for Margo, Kick Cancer and Kriibskrank Kanner Foundation) is the funding institution.

L’Associació Pulseras Candela consolida la seva col·laboració amb una nova aportació de 50.000€ al projecte del Dr. Miquel Segura i la Dra. Roberta Antonelli del VHIR.

On the occasion of World Cancer Research Day, we remember the work of VHIO and VHIR researchers to advance in the field of oncology.